Adding to the accumulating data on solid tumors, a recently increasing number of studies investigate the role of the NLRP3 inflammasome in the pathogenesis of hematologic malignancies, with most of them focusing on neoplasms of myeloid origin [21,22,23]. Here, NLRP3 is linked to hematologic disorder.